<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lenalidomide is known to be effective in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with del(5q) in improving <z:hpo ids='HP_0001903'>anemia</z:hpo> and suppressing del(5q) cells </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with del(5q) shows increase of nonlobulated megakaryocytes </plain></SENT>
<SENT sid="2" pm="."><plain>However, histopathology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with del(5q) treated with lenalidomide has not been fully studied </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated the morphologic changes in lenalidomide treated low- or intermediate-1-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with del(5q) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of evaluable patients showed high proportion of nonlobulated megakaryocytes </plain></SENT>
<SENT sid="5" pm="."><plain>The nonlobulated megakaryocytes were markedly decreased in 6 patients during therapy in parallel with suppression of del(5q) cells </plain></SENT>
<SENT sid="6" pm="."><plain>Our analysis suggests that single allele deletion of common deleted region inhibits nuclear lobulation of megakaryocytes </plain></SENT>
</text></document>